These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 35571123)
21. Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma. Yu W; Ma Y; Hou W; Wang F; Cheng W; Qiu F; Wu P; Zhang G Front Immunol; 2021; 12():706936. PubMed ID: 34899682 [TBL] [Abstract][Full Text] [Related]
22. A Novel Ferroptosis-Related Gene Risk Signature for Predicting Prognosis and Immunotherapy Response in Gastric Cancer. Liu SJ; Yang YB; Zhou JX; Lin YJ; Pan YL; Pan JH Dis Markers; 2021; 2021():2385406. PubMed ID: 34868391 [TBL] [Abstract][Full Text] [Related]
23. A Ferroptosis-Related Genes Model Allows for Prognosis and Treatment Stratification of Clear Cell Renal Cell Carcinoma: A Bioinformatics Analysis and Experimental Verification. Wu J; Sun Z; Bi Q; Wang W Front Oncol; 2022; 12():815223. PubMed ID: 35155251 [TBL] [Abstract][Full Text] [Related]
24. An integrative characterization of recurrent molecular aberrations in glioblastoma genomes. Sintupisut N; Liu PL; Yeang CH Nucleic Acids Res; 2013 Oct; 41(19):8803-21. PubMed ID: 23907387 [TBL] [Abstract][Full Text] [Related]
25. A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer. Yang L; Li C; Qin Y; Zhang G; Zhao B; Wang Z; Huang Y; Yang Y Front Oncol; 2021; 11():686044. PubMed ID: 34422642 [TBL] [Abstract][Full Text] [Related]
26. Identification of a Ferroptosis Gene Set That Mediates the Prognosis of Squamous Cell Carcinoma of the Head and Neck. Li C; Wang X; Qin R; Zhong Z; Sun C Front Genet; 2021; 12():698040. PubMed ID: 34539737 [TBL] [Abstract][Full Text] [Related]
27. Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database. Lei CG; Jia XY; Sun WJ Yi Chuan; 2021 Jul; 43(7):665-679. PubMed ID: 34284982 [TBL] [Abstract][Full Text] [Related]
28. Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients. Du S; Zeng F; Sun H; Liu Y; Han P; Zhang B; Xue W; Deng G; Yin M; Cui B Bioengineered; 2022 Feb; 13(2):2498-2512. PubMed ID: 35067161 [TBL] [Abstract][Full Text] [Related]
29. Development and validation of a ferroptosis-related prognostic model in pancreatic cancer. Qiu CJ; Wang XB; Zheng ZR; Yang CZ; Lin K; Zhang K; Tu M; Jiang KR; Gao WT Invest New Drugs; 2021 Dec; 39(6):1507-1522. PubMed ID: 34195903 [TBL] [Abstract][Full Text] [Related]
30. Identification of a Novel Ferroptosis-Related Gene Prediction Model for Clinical Prognosis and Immunotherapy of Colorectal Cancer. Yang YB; Zhou JX; Qiu SH; He JS; Pan JH; Pan YL Dis Markers; 2021; 2021():4846683. PubMed ID: 34868393 [TBL] [Abstract][Full Text] [Related]
31. Novel Prognostic Signature for Acute Myeloid Leukemia: Bioinformatics Analysis of Combined CNV-Driven and Ferroptosis-Related Genes. Han C; Zheng J; Li F; Guo W; Cai C Front Genet; 2022; 13():849437. PubMed ID: 35559049 [No Abstract] [Full Text] [Related]
32. Comprehensive analysis of new prognostic signature based on ferroptosis-related genes in clear cell renal cell carcinoma. Zheng B; Niu Z; Si S; Zhao G; Wang J; Yao Z; Cheng F; He W Aging (Albany NY); 2021 Aug; 13(15):19789-19804. PubMed ID: 34370716 [TBL] [Abstract][Full Text] [Related]
33. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes. Diao X; Guo C; Liu L; Wang G; Li S Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420 [TBL] [Abstract][Full Text] [Related]
34. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas. Zhao WJ; Ou GY; Lin WW Front Immunol; 2021; 12():682415. PubMed ID: 34054873 [TBL] [Abstract][Full Text] [Related]
35. Identification of Candidate Genes Associated With Prognosis in Glioblastoma. Li R; Jiang Q; Tang C; Chen L; Kong D; Zou C; Lin Y; Luo J; Zou D Front Mol Neurosci; 2022; 15():913328. PubMed ID: 35875673 [TBL] [Abstract][Full Text] [Related]
36. Identification of aberrantly methylated differentially expressed genes in glioblastoma multiforme and their association with patient survival. Zhang M; Lv X; Jiang Y; Li G; Qiao Q Exp Ther Med; 2019 Sep; 18(3):2140-2152. PubMed ID: 31452706 [TBL] [Abstract][Full Text] [Related]
37. Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction and immunotherapy response in patients with NSCLC. Li M; Zhang Y; Fan M; Ren H; Chen M; Shi P BMC Med Genomics; 2021 Dec; 14(1):286. PubMed ID: 34861872 [TBL] [Abstract][Full Text] [Related]
38. Prognostic and Predictive Models for Left- and Right- Colorectal Cancer Patients: A Bioinformatics Analysis Based on Ferroptosis-Related Genes. Chen Y; Li H Front Oncol; 2022; 12():833834. PubMed ID: 35265525 [TBL] [Abstract][Full Text] [Related]
39. Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme. Li H; Wang D; Yi B; Cai H; Xi Z; Lou X; Li Z Biomed Res Int; 2021; 2021():8357585. PubMed ID: 34395626 [TBL] [Abstract][Full Text] [Related]
40. Identification of a key glioblastoma candidate gene, FUBP3, based on weighted gene co-expression network analysis. Li J; Zhang Z; Guo K; Wu S; Guo C; Zhang X; Wang Z BMC Neurol; 2022 Apr; 22(1):139. PubMed ID: 35413821 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]